Scroll to Top

FDA head calls for investigation into approval of controversial Alzheimer’s drug

By / Published on Saturday, 10 Jul 2021 03:48 AM / Comments Off on FDA head calls for investigation into approval of controversial Alzheimer’s drug / 18 views



In a letter, FDA Commissioner Janet Woodcock wrote that she’s concerned about “contacts between representatives from Biogen and FDA during the review process, including some that may have occurred outside of the formal correspondence process.”